Lymphocyte Antigen 9 (LY9) ELISA Kits

LY9 belongs to the SLAM family of immunomodulatory receptors (see SLAMF1\; MIM 603492) and interacts with the adaptor molecule SAP (SH2D1A\; MIM 300490) (Graham et al., 2006 [PubMed 16365421]).[supplied by OMIM, Mar 2008].. Additionally we are shipping LY9 Antibodies (134) and LY9 Proteins (21) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
LY9 4063 Q9HBG7
LY9 17085 Q01965
Anti-Rat LY9 LY9 289227  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top LY9 ELISA Kits at

Showing 3 out of 11 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Supplier Delivery Price Details
Human 7.81 pg/mL 31.25-2000 pg/mL Typical standard curve 96 Tests Log in to see 15 to 18 Days
Mouse 45.22 pg/mL 78.13-5000 pg/mL This standard curve is only for demonstration purposes. A standard curve should be generated for each assay. This assay recognizes recombinant Mouse LY9. The factors listed below were prepared at 50 ng/mL in dilution buffer and assayed for cross-reactivity. No cross-reactivity was observed. 96 Tests Log in to see 20 to 21 Days
Human 50 pg/mL 81.9 pg/mL - 20000 pg/mL   96 Tests Log in to see 5 to 8 Days

More ELISA Kits for LY9 Interaction Partners

Human Lymphocyte Antigen 9 (LY9) interaction partners

  1. Authors make a strong correlation between induced SLAMF3 overexpression and the specific loss of MRP-1 (show MDM4 ELISA Kits) expression and its functionalities as a drugs resistance transporter.

  2. the results presented here suggest that the tumor suppressor potential of SLAMF3 occurs through activation of Retinoblastoma protein that represses PLK1 (show PLK1 ELISA Kits).

  3. study showed CD229 is overexpressed on the malignant plasma cells of patients across all types of plasma cell dyscrasias including multiple myeloma; CD229 is also expressed on the surface of a fraction of cells carrying the phenotype of chemotherapy-resistant and myeloma-propagating cells within the patients' bone marrow

  4. the Val602 variant of the non-synonymous single nucleotide polymorphism (SNP) rs509749 in the SLAM (show SLAMF1 ELISA Kits) family member CD229 (Ly9, SLAMF3) has a two-fold lower affinity compared with the SLE-associated Met602 variant for the small adaptor protein SAP (show APCS ELISA Kits)

  5. CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain Significance.

  6. Results revealed that SLAMF3 plays a role during hepatitis C virus entry, likely by enhancing entry of viral particle within hepatocytes.

  7. SLAMF3 is an inhibitor of hepatocellular carcinoma cell proliferation and tumor progression.

  8. These results suggest a role for CD319 (show SLAMF7 ELISA Kits) and CD229 in the systemic lupus erythematosus disease process.

  9. Data indicate that the dominance of the SLAMF3/SLAMF6 (show SLAMF6 ELISA Kits) pathway in inducing IL-17A (show IL17A ELISA Kits) production can be attributed to an increased nuclear abundance and recruitment of RORgammat to the IL17A (show IL17A ELISA Kits) promoter.

  10. SLAMF3 and SLAMF6 (show SLAMF6 ELISA Kits) T cell surface expression and IL-17 (show IL17A ELISA Kits) levels significantly correlate with disease activity in systemic lupus erythematosus patients

Mouse (Murine) Lymphocyte Antigen 9 (LY9) interaction partners

  1. The authors show that Ly9 influences Invariant natural killer T cell lineage differentiation. Furthermore, treatment of wild-type mice with an agonistic monoclonal antibody directed against Ly9 impaired IL-4 (show IL4 ELISA Kits) and IFN-gamma (show IFNG ELISA Kits) production and reduced by half the number of spleen iNKT cells, with a significant decrease in the proportion of NKT2 cells.

  2. SLAMF3 is an inhibitor of hepatocellular carcinoma cell proliferation and tumor progression.

  3. Ly9/CD229 cell surface receptor emerges as a uniquely important element for modulating innate T cell function, acting as an inhibitory molecule that regulates invariant natural killer (NK)T cell development and innate-like CD8 (show CD8A ELISA Kits) T cell expansion.

  4. Data show that defective tolerance was observed only in Fcgr2b-deficient mice with autoimmune-type Slam (show SLAMF1 ELISA Kits) family genes, indicating that epistatic effects of both genes are involved.

  5. mouse novel Ly9 (show SLAMF7 ELISA Kits) is a new member of the expanding CD150 (show SLAMF1 ELISA Kits) family of cell surface receptors

  6. CD229 is a self-ligand, interacting through its N-terminal V-like domain which contains three amino acid residues critical for the homophilic binding interaction.

  7. CD229 is a pan-lymphocyte marker and indicate that mAbs against CD229 are able to down-modulate T-cell activation.

LY9 Antigen Profile

Antigen Summary

LY9 belongs to the SLAM family of immunomodulatory receptors (see SLAMF1\; MIM 603492) and interacts with the adaptor molecule SAP (SH2D1A\; MIM 300490) (Graham et al., 2006

Gene names and symbols associated with Lymphocyte Antigen 9 (LY9) ELISA Kits

  • lymphocyte antigen 9 (LY9) antibody
  • lymphocyte antigen 9 (Ly9) antibody
  • AI893573 antibody
  • CD229 antibody
  • hly9 antibody
  • Lgp100 antibody
  • Ly-9 antibody
  • LY9 antibody
  • mLY9 antibody
  • SLAMF3 antibody
  • T100 antibody

Protein level used designations for Lymphocyte Antigen 9 (LY9) ELISA Kits

lymphocyte antigen 9 , T-lymphocyte surface antigen Ly-9 , T-lymphocyte surface antigen Ly-9-like , t-lymphocyte surface antigen Ly-9-like , SLAM family member 3 , cell surface molecule Ly-9 , signaling lymphocytic activation molecule 3

457438 Pan troglodytes
488643 Canis lupus familiaris
528926 Bos taurus
100155269 Sus scrofa
100406059 Callithrix jacchus
100437582 Pongo abelii
100465450 Ailuropoda melanoleuca
4063 Homo sapiens
17085 Mus musculus
289227 Rattus norvegicus
Selected quality suppliers for LY9 (LY9) ELISA Kits
Did you look for something else?